Louisville, CO, United States of America

Christopher B Glascock


Average Co-Inventor Count = 8.7

ph-index = 4

Forward Citations = 220(Granted Patents)


Company Filing History:


Years Active: 2002-2007

Loading Chart...
4 patents (USPTO):

Title: The Innovative Mind of Christopher B. Glascock

Introduction

Christopher B. Glascock is an accomplished inventor based in Louisville, Colorado. With a total of four patents to his name, he has significantly contributed to advancements in hemoglobin compositions and their therapeutic applications. His innovations have the potential to revolutionize treatments in various medical fields.

Latest Patents

Christopher’s latest patents are centered around enhancing hemoglobin compositions. His first notable invention is a reduced side-effect hemoglobin composition, which addresses significant concerns associated with the administration of extracellular hemoglobin. This groundbreaking invention aims to eliminate or greatly reduce heart lesions, gastrointestinal discomfort, pressor effects, and endotoxin hypersensitivity. The applications of this invention are vast, including treatments for anemia, head injuries, hemorrhage, ischemia, cachexia, sickle cell crisis, stroke, enhancing cancer treatments, and improving the healing of damaged tissues.

His second recent patent focuses on hemoglobin mutants designed for increased soluble expression and reduced nitric oxide scavenging. This innovation involves novel recombinant hemoglobins that enhance soluble expression by incorporating exogenous hemin, which plays a crucial role in the heme binding sites of recombinant hemoglobin.

Career Highlights

Throughout his career, Christopher B. Glascock has worked with renowned organizations, including Baxter International Inc. His endeavors in research and development have culminated in groundbreaking innovations that benefit numerous medical applications.

Collaborations

Collaboration plays a pivotal role in Christopher’s success as an inventor. He has worked alongside accomplished professionals in the field, including Douglas D. Lemon and Douglas L. Looker. These partnerships have aided in refining his inventions and pushing the boundaries of medical science.

Conclusion

Christopher B. Glascock’s intelligence and creativity in the realm of hemoglobin compositions exemplify his status as a vital contributor to medical innovation. His patents reflect a commitment to improving patient outcomes through advanced therapeutic solutions. As he continues to innovate, the medical community eagerly anticipates the positive impact of his work on future treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…